tradingkey.logo

Accuray Inc

ARAY
查看詳細走勢圖
0.620USD
+0.020+3.32%
收盤 02/06, 16:00美東報價延遲15分鐘
70.27M總市值
虧損本益比TTM

Accuray Inc

0.620
+0.020+3.32%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+3.32%

5天

-23.20%

1月

-29.04%

6月

-53.03%

今年開始到現在

-24.81%

1年

-74.49%

查看詳細走勢圖

TradingKey Accuray Inc股票評分

單位: USD 更新時間: 2026-02-06

操作建議

Accuray Inc當前公司基本面數據相對穩定,最新ESG揭露屬於行業領先水平。增長潛力很大。當前估值合理,在醫療設備與耗材行業排名74/205位。機構持股佔比非常高,近一月多位分析師給出公司評級為強力買入。最高目標價為2.52。中期看,股價處於下降通道。近一個月,市場表現非常差,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Accuray Inc評分

相關信息

行業排名
74 / 205
全市場排名
204 / 4521
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
看空

Accuray Inc亮點

亮點風險
Accuray Incorporated is a radiation therapy company. The Company develops, manufactures, sells and supports solutions that are designed to deliver radiation treatments for complex cases. Its solutions are designed to advance patient care: during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, it also provides services, which include post-contract customer support (warranty period services and post-warranty services), installation services, training, and other professional services.
估值高估
公司最新PE估值-2.09,處於3年歷史高位
機構減倉
最新機構持股79.19M股,環比減少0.02%
PRFDX持倉
明星投資者PRFDX持倉,最新持倉10.25K股

分析師目標

基於 2 分析師
強力買入
評級
2.525
目標均價
+233.73%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Accuray Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Accuray Inc簡介

Accuray Incorporated is a radiation therapy company. The Company develops, manufactures, sells and supports solutions that are designed to deliver radiation treatments for complex cases. Its solutions are designed to advance patient care: during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, it also provides services, which include post-contract customer support (warranty period services and post-warranty services), installation services, training, and other professional services.
公司代碼ARAY
公司Accuray Inc
CEOLa Neve (Stephen R)
網址https://www.accuray.com/
KeyAI